These direct targets comprise the first SCLC-based ATOH1 gene signature consistently observed in CDXs, PDXs, and tumor biopsies, indicative of a conserved transcriptional role for ATOH1 in SCLC. This evidence concerns the gene ATOH1 and neoplasm.